Picture of Kyntra Bio logo

KYNB — Kyntra Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Fibrogen Announces Sale Of Fibrogen China To Astrazeneca For About $160 Million

Feb 20 (Reuters) - FibroGen Inc  FGEN.O :
    * FIBROGEN ANNOUNCES THE SALE OF FIBROGEN CHINA TO
ASTRAZENECA
FOR APPROXIMATELY $160 MILLION
    * FIBROGEN INC - ANNOUNCES SALE OF CHINA SUBSIDIARY TO
ASTRAZENECA
FOR $160 MILLION
    * FIBROGEN INC - CASH RUNWAY EXTENDED INTO 2027

Source text:  ID:nGNXtnJ8x 
Further company coverage:  FGEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kyntra Bio

See all news